NCT05842811View on ClinicalTrials.gov

An Observational Study of Patients With Metabolic Syndrome and Related Conditions

Not yet recruitingOBSERVATIONAL

Enrollment

2,000,000

Participants

Timeline

Start Date

May 24, 2023

Primary Completion Date

December 31, 2038

Study Completion Date

December 31, 2038

Conditions

Metabolic Syndrome

All Listed Sponsors

lead

Target PharmaSolutions, Inc.

INDUSTRY

NCT05842811 - An Observational Study of Patients With Metabolic Syndrome and Related Conditions | Biotech Hunter | Biotech Hunter